Latest receivables for IPAH: $14M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Interpharm Holdings (IPAH) currently reports a receivables of $14M as of December 2007. That compares with $11M in the prior-year period — up 20.9% year over year. Use the charts on this page to explore Interpharm Holdings's receivables history and peer comparisons.
Interpharm Holdings's receivables increased from $11M to $14M — a 20.9% year-over-year increase (period ending December 2007). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Interpharm Holdings reported $14M in receivables as of December 2007. That compares with $11M in the prior-year period — up 20.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Interpharm Holdings, and consider following IPAH for alerts when major investors trade the stock.